Catecholamine derivatives useful for the treatment of Parkinson' s disease

Details for Australian Patent Application No. 2008291425 (hide)

Owner H. Lundbeck A/S

Inventors Mork, Niels; Puschl, Ask; Bang-Andersen, Benny; Larsen, Jennifer; Jorgensen, Morten

Agent Watermark

Pub. Number AU-A-2008291425

PCT Pub. Number WO2009/026934

Priority PA200701250 31.08.07 DK

Filing date 28 August 2008

Wipo publication date 5 March 2009

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4741 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/026934 Priority application(s): WO2009/026934

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008291426-Catecholamine derivatives and prodrugs thereof

2008291407-Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2 -trifluoroethoxy)methyl]phenyl}carbonyl)cyclohexan e-1,3-dione